Vickers Vantage Corp I Warrants (SCLXW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Vickers Vantage Corp I Warrants (SCLXW:NASDAQ), powered by AI.

Current Price
$0.17
Sector
Healthcare
What is the Vickers Vantage Corp I Warrants stock price forecast?

Vickers Vantage Corp I Warrants is currently trading at $0.17. View real-time AI analysis on Alpha Lenz.

What is Vickers Vantage Corp I Warrants insider trading activity?

View the latest insider trading data for Vickers Vantage Corp I Warrants on Alpha Lenz.

What is Vickers Vantage Corp I Warrants's P/E ratio?

View Vickers Vantage Corp I Warrants's valuation metrics on Alpha Lenz.

Vickers Vantage Corp I Warrants

NASDAQ · SCLXW
$0.17-0.04(-17.98%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Vickers Vantage Corp I Warrants's future dividend policy...
Alpha Chat Insight

Vickers Vantage Corp I Warrants's ROE is 179.2%. Explore profitability and growth together.

Ask for details

Company Overview

Vickers Vantage Corp I Warrants are financial derivatives that grant the holder the right to purchase shares of Vickers Vantage Corp I at a predetermined price before a specified expiration date. These warrants are instrumental in raising capital for the company, providing potential investors with an opportunity to participate in the company's growth while securing additional financing. Warrants are typically issued alongside other securities to sweeten the deal for investors and may be traded separately from their associated shares. The primary function of these warrants is to allow investors to leverage their positions, offering an opportunity to capitalize on the potential upside without initially requiring full investment in the underlying shares. The issuance of such warrants by Vickers Vantage Corp I plays a strategic role in its financial planning, potentially aiding in mergers, acquisitions, or other corporate financing activities. In the broader market context, these warrants add an element of diversity and flexibility to investors' portfolios, enabling proactive financial strategies in sectors that Vickers Vantage Corp I operates within.

CEODr. Henry H. Ji Ph.D.
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31

Company Statistics

FY 2025

Profile

N/AMarket Cap
$30.25MRevenue
0.00Shares Out
31Employees

Margins

64.97%Gross
-772.20%EBITDA
-900.09%Operating
-1236.33%Pre-Tax
-1236.42%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-7.35%Rev 3Yr
5.13%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-163.37%ROA
179.18%ROE
-158.35%ROIC

Financial Health

$4.96MCash & Cash Equivalents
$571.78MNet Debt
-272.36%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Vickers Vantage Corp I Warrants (ticker: SCLXW) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - General). It has approximately 31 employees.

The current price is $0.17 with a P/E ratio of -x and P/B of -x.

ROE is 179.18% and operating margin is -900.09%. Annual revenue is $30M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Vickers Vantage Corp I Warrants (SCLXW) Stock Forecast 2026 $0.17 — Price, Financials & Analyst Targets | Alpha Lenz